BNTC
NASDAQ
US
Benitec Biopharma Inc. - Common Stock
$10.92
▼ $-0.05
(-0.46%)
Vol 54K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$456.1M
ROE
-37.2%
Margin
-20671.4%
D/E
0.00
Beta
0.28
52W
$10–$17
Wall Street Consensus
13 analysts · Apr 20266
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
92.3%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 12, 2026
EPS Estimate: $-0.28
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2026 | $-0.28 | — | — |
| Dec 2025 | $-0.23 | $-0.26 | $-0.03 |
| Sep 2025 | $-0.38 | $-0.22 | +$0.16 |
| Jun 2025 | $-0.30 | $-0.42 | $-0.12 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$9.6M | -$9.4M | -$16.1M | -$9.0M | -$11.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -37.2% | -37.2% | -37.2% | -37.2% | -37.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -20671.4% | -20671.4% | -20671.4% | -20671.4% | -20671.4% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | — | 14.80 | 14.80 | 14.80 | 14.80 | 14.80 |
Key Ratios
ROA (TTM)
-34.7%
P/S (TTM)
6516.06
P/B
1.4
EPS (TTM)
$-1.18
CF/Share
$-14.00
52W High
$17.15
52W Low
$9.70
$9.70
52-Week Range
$17.15
Financial Health
Free Cash Flow
-$3.8M
Net Debt
-$187.8M
Cash
$188.8M
Total Debt
$987K
As of Dec 31, 2025
How does BNTC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BNTC valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6516.1
▲
50609%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.5
▼
41%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BNTC profitability vs Biotechnology peers
ROE
-37.2%
▲
45%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-20671.4%
▼
7109%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
100.0%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-34.7%
▲
26%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
BNTC financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
14.8
▲
233%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼
71%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
BNTC fundamentals radar
BNTC
Peer median
Industry
BNTC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BNTC vs peers: key metrics
Top Holders
Top 5: 60.06%Suvretta Capital Management…
33.62%
$118.6M
Janus Henderson Group PLC
8.48%
$29.9M
Franklin Resources, Inc.
6.40%
$22.6M
Adage Capital Partners GP L…
6.17%
$21.8M
RA Capital Management, L.P.
5.39%
$19.0M
As of Dec 31, 2025
Dividends
$0.77
/ year
Jun 01, 2018
$0.7650
Latest News
No related news yet